Wednesday, January 18, 2017

BRIEF-Paratek announces completion of enrollment in Omadacycline phase 3 community-acquired bacterial pneumonia study

* Paratek announces completion of enrollment in Omadacycline

phase 3 community-acquired bacterial pneumonia study

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)